Jeff Yass’s AEON Biopharma Inc AEON.WS Stock Holding History

Jeff Yass’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,009	Closed	-$1K	–	14060
2022 Q3	$1K	Buy	+17,009	New	+$1.55K	﹤0.01%	13005

Other funds holding AEON.WS

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Parallax Volatility Advisers

Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Jeff Yass's AEON.WS Position: Q4 2022 in Review

Jeff Yass sold out of AEON Biopharma Inc (AEON.WS) in Q4 2022, closing a stake of 17,009 shares — an estimated $1K sold.

Jeff Yass first reported a position in AEON.WS in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 52 funds tracked by Wall St. Rank hold AEON.WS as of Q4 2022.

Jeff Yass reported no remaining AEON Biopharma Inc position as of Q4 2022 after selling out during the quarter.
Jeff Yass sold 17,009 AEON Biopharma Inc shares in Q4 2022, an estimated $1K.
Jeff Yass first reported a position in AEON Biopharma Inc in Q3 2022 and held it in 1 quarter.
Jeff Yass's AEON Biopharma Inc position peaked at $1K in Q3 2022.
52 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.